Upgrade subject to access all content
A pharmaceutical company designs a drug to reduce cellular response to estrogen.
Which of the following would be the MOST likely result of taking this drug?
A reduction in the transcription activity of certain genes.
Increased concentrations of phosphodiesterase.
Reduction in blood calcium levels.
Removal of serine acceptors.